e-learning
resources
Virtual 2020
Monday, 07.09.2020
Right ventricular function and pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Pulmonary embolism in patients with COVID-19: Time to change thromboprophylaxis paradigm.
A. Mahalingam (Basildon, United Kingdom), A. Elsheikh (Basildon, United Kingdom), M. Shafiq (Basildon, United Kingdom), M. Pittman (Basildon, United Kingdom)
Source:
Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Session:
Right ventricular function and pulmonary hypertension
Session type:
Oral Presentation
Number:
4041
Disease area:
Pulmonary vascular diseases, Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Mahalingam (Basildon, United Kingdom), A. Elsheikh (Basildon, United Kingdom), M. Shafiq (Basildon, United Kingdom), M. Pittman (Basildon, United Kingdom). Late Breaking Abstract - Pulmonary embolism in patients with COVID-19: Time to change thromboprophylaxis paradigm.. 4041
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Related content which might interest you:
Late Breaking Abstract - Pulmonary embolism in patients admitted by COVID-19. Incidence and features.
Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Year: 2020
Late Breaking Abstract - An evaluation of standard UK pulmonary rehabilitation post pulmonary embolism
Source: International Congress 2018 – Acute pulmonary embolism: from diagnosis to treatment
Year: 2018
Late Breaking Abstract - Outpatient pulmonary rehabilitation in patients with long COVID
Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care
Year: 2021
Late Breaking Abstract - Increased risk of pulmonary embolism in patients with radiological severe COVID-19 pneumonia
Source: Virtual Congress 2020 – COVID-19 clinical studies
Year: 2020
Late Breaking Abstract - Early ICU physiotherapy on SARS-CoV-2 patients: A Spanish experience case series
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2
Year: 2020
Late Breaking Abstract - Use of a simple telecoaching pulmonary rehabilitation protocol for COPD patients.
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019
Late Breaking Abstract - Frequency Pulmonary embolism (PE) in patients with an acute Exacerbation of chronic obstructive Pulmonary disease (COPD). PEP prospective trial.
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019
Duration of treatment in acute pulmonary embolism: time for a change?
Source: International Congress 2017 – Open questions in pulmonary vascular diseases
Year: 2017
Late Breaking Abstract - Physical activity recovery in patients with COVID-19 infection included in pulmonary rehabilitation
Source: Virtual Congress 2021 – COVID-19: insights from respiratory physiotherapists
Year: 2021
Late Breaking Abstract - Development of an animal model for group 3 Pulmonary Hypertension
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018
Late Breaking Abstract - Incidence, risk factors and thrombotic load of pulmonary embolism in patients hospitalized with COVID-19
Source: Virtual Congress 2021 – Insights into pulmonary embolism
Year: 2021
Late Breaking Abstract - Lung deflation with Indacaterol/Glycopyrronium improves cardiac function in COPD patients: The CLAIM Study
Source: International Congress 2017 – Update and new perspectives in Airway Diseases
Year: 2017
Pulmonary embolism and COVID-19: a “special phenotype”?
Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Year: 2021
Late Breaking Abstract - Pulmonary function in children and adolescents after COVID-19
Source: Virtual Congress 2021 – Best of paediatric physiology and sleep research
Year: 2021
An overview of thrombolytic treatment for pulmonary embolism: A single center experience
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Late Breaking Abstract - Exercise rehabilitation in telemedicine for COVID-19 patients.
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020
Late Breaking Abstract - Covid-19 management in an Italian Prison. Monitoring of pulmonary function using oscillometry.
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021
Late Breaking Abstract - Pneumonectomy in patients with reduced pulmonary function: complications and 30-day mortality
Source: International Congress 2019 – General thoracic surgery
Year: 2019
Rivaroxaban for treatment of venous thromboembolism. A real-life perspective in 103 patients
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept